Benefits of PARP Inhibitor Use in Breast Cancer

JENNIFER LITTON, MD

Friday, January 11, 2019

Jennifer Litton, MD, Breast Medical Oncologist, MD Anderson Cancer Center, describes how PARP inhibitors compare to standard of care in breast cancer treatment.

Discussions >>

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.

Related Videos

Challenges in Oncology Pharmacy

By: Howard Cohen, RPh, MS, FASHP

Precision Cancer Therapies Program Brings New Hope to Gulf Region

By: Marc Matrana, MD, MS, FACP

Nurse Leaders Incorporate More Kindness Into Their Work to Combat Burnout

By: Julie Kennedy Oehlert, DNP

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions